metric stringclasses 27
values | status stringclasses 3
values | table_name stringlengths 7 51 | value stringlengths 1 162 |
|---|---|---|---|
row_count | ok | sources.csv | 144 |
row_count | ok | controls.csv | 161 |
row_count | ok | oligos.csv | 1120 |
row_count | ok | chemical_modifications.csv | 1120 |
row_count | ok | biophysical_properties.csv | 1120 |
row_count | ok | dose_exposure.csv | 1120 |
row_count | ok | nanoparticle_delivery.csv | 1120 |
row_count | ok | rna_payload_systems.csv | 1120 |
row_count | ok | lipid_homeostasis.csv | 1120 |
row_count | ok | epigenetic_liver_context.csv | 1120 |
row_count | ok | angptl3_liver_safety.csv | 1120 |
row_count | ok | pnpla3_precision_context.csv | 1120 |
row_count | ok | extrahepatic_delivery.csv | 1120 |
row_count | ok | personalized_aso_workflow.csv | 1120 |
row_count | ok | aso_metabolic_nafld_context.csv | 1120 |
row_count | ok | sequence_modification_toxicity.csv | 1120 |
row_count | ok | hsd17b13_rapirosiran_clinical_pd.csv | 1120 |
row_count | ok | hbv_rnai_escplus_safety.csv | 1120 |
row_count | ok | zilebesiran_raas_safety.csv | 1120 |
row_count | ok | sirna_bulge_offtarget_tolerance.csv | 1120 |
row_count | ok | fbll1_hcc_spatial_oncogenic_context.csv | 1120 |
row_count | ok | galnac_lnp_mkk4_liver_regeneration.csv | 1120 |
row_count | ok | ogt_sev_lsec_masld_context.csv | 1120 |
row_count | ok | malat1_hbv_hcc_aso_context.csv | 1120 |
row_count | ok | cd133_masld_hcc_sirna_context.csv | 1120 |
row_count | ok | galnac_rbc_ev_liver_delivery.csv | 1120 |
row_count | ok | meldplus_cirrhosis_risk_context.csv | 1120 |
row_count | ok | formononetin_aldh2_nrf2_ald_context.csv | 3 |
row_count | ok | hnp_hoxb7_tamoxifen_nanoparticle_context.csv | 3 |
row_count | ok | pmevl_sev_rna_loading_pcsk9_context.csv | 17 |
row_count | ok | preclinical_oligo_safety_assessment.csv | 26 |
row_count | ok | ifna_disulfidptosis_hcc_context.csv | 44 |
row_count | ok | galnac_sirna_nonclinical_safety.csv | 319 |
row_count | ok | inclisiran_fh_realworld_context.csv | 33 |
row_count | ok | reviewed_not_encoded_sources.csv | 1 |
row_count | ok | galnac_liver_delivery_review_context.csv | 196 |
row_count | ok | sirna_pharmacology_clinical_development_context.csv | 4 |
row_count | ok | aso_gapmer_hepatotoxicity_screening.csv | 43 |
row_count | ok | ago1_lnp_aso_endothelial_liver_vascular_context.csv | 4 |
row_count | ok | assays.csv | 5600 |
row_count | ok | toxicity_readouts.csv | 16800 |
row_count | ok | generated_records.csv | 17920 |
row_count | ok | assumptions.csv | 76 |
row_count | ok | provenance.csv | 144 |
row_count | ok | data_dictionary.csv | 259 |
hepatotoxicity_label_count | ok | toxicity_readouts.csv | low:1712 |
hepatotoxicity_label_count | ok | toxicity_readouts.csv | moderate:4505 |
hepatotoxicity_label_count | ok | toxicity_readouts.csv | high:10583 |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_VEHICLE_MOCK |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_LOW_RISK_OLIGO |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_CLINICAL_LOW_HEPATOTOX_RAPIROSIRAN |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_HUMAN_LIVER_SPHEROID_TOLERATED |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_HIGH_PS_HIGH_DOSE |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_HIGH_OFFTARGET |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_TRANSCRIPTOMIC_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_LNA_GAPMER_HIGH_RISK |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_TARGETED_LNP_ASGPR_SAFE_WINDOW |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_DELIVERY_RELATED_NP_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_BALANCED_HYBRID_RNA_LNP |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_IMMUNE_ACTIVATING_RNA_LNP_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_APOB_ASO_LOW_LIPID_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_APOB_ASO_LIPID_EXPORT_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_SULT1B1_SIRNA_LIPID_RESCUE |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_MASLD_EPIGENETIC_LIPID_ACCUMULATION |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_ANGPTL3_SIRNA_LIVER_SAFETY |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_ANGPTL3_ASO_HEPATIC_FAT_ALT_SIGNAL |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_PNPLA3_I148M_HOMOZYGOUS_LIPID_STRESS |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_PNPLA3_SIRNA_HOMOZYGOTE_RESCUE |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_PNPLA3_HETEROZYGOUS_UNCERTAIN_RESPONSE |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_CHOLESTEROL_SIRNA_MUSCLE_TOLERATED |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_EXTRAHEPATIC_SIRNA_LIVER_EXPOSURE |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_PERSONALIZED_ASO_ACCEPTABLE_SAFETY_PROFILE |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_CUSTOM_ASO_TOX_WORKFLOW |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_GALNAC_ASO_NAFLD_TARGETED_LIVER_SAFE_WINDOW |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_HIGH_AFFINITY_GAPMER_HEPATOTOX_SEQUENCE_MOTIF |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_ASO_TYPE_I_IFN_OFFTARGET |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_LNA_GAPMER_SEQUENCE_REDESIGN_LOW_TOX |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_LNA_GAPMER_SEQUENCE_PATTERN_HIGH_TOX |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_DISTANCE_LIMITED_SEQUENCE_TOX_PREDICTION |
control_present_in_oligos | warning_missing | oligos.csv | CTRL_NEG_HSD17B13_RAPIROSIRAN_NO_DILI_PD |
control_present_in_oligos | warning_missing | oligos.csv | CTRL_CONTEXT_HSD17B13_HEPATITIS_E_CONFOUNDED_ALT_AST |
control_present_in_oligos | warning_missing | oligos.csv | CTRL_CONTEXT_HSD17B13_PLACEBO_MASH_ALT_AST_REFERENCE |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_VIR2218_ESCPLUS_LOW_ALT |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_ALNHBV_SEED_OFFTARGET_ALT |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_VIR2218_CHBV_HBSAG_REDUCTION |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_ZILEBESIRAN_GALNAC_AGT_PLATFORM_LOW_HEPATIC_INJURY |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_ZILEBESIRAN_RAAS_HYPERKALEMIA_RENAL_MONITORING |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_ZILEBESIRAN_LONG_PD_ENDOSOMAL_DEPOT |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_TTR_GALNAC_SIRNA_BULGE14_ACTIVE_LOW_TOX |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_TERMINAL_BULGE_OFFTARGET_REPRESSION_RISK |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_SEED_REGION_BULGE_ACTIVITY_LOSS |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_FBLL1_HIGH_HCC_MALIGNANT_STATE |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_FBLL1_SIRNA_KNOCKDOWN_HCC_GROWTH_SUPPRESSION |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_FBLL1_CMYC_EGFR_MAPK_ACTIVATION |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_GALNAC_LNP_SIMKK4_BIOCOMPATIBLE_LOW_HEMOLYSIS |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_GALNAC_LNP_SIMKK4_ACLF_REGENERATION |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_CCL4_PHX_ACLF_INJURY_CONTEXT |
control_present_in_oligos | ok | oligos.csv | CTRL_POS_OGT_SEV_LSEC_CAPILLARIZATION_MASLD |
control_present_in_oligos | ok | oligos.csv | CTRL_NEG_OGT_KNOCKDOWN_SEV_REDUCED_CAPILLARIZATION |
control_present_in_oligos | ok | oligos.csv | CTRL_CONTEXT_BAGN_OGLCNAC_INHIBITOR_MASLD_RESCUE |
OligoTox Phase 2 Dataset
A computationally generated, AI-ready, literature-informed dataset for modeling oligonucleotide-associated hepatotoxicity. Released by DBbun LLC as part of a submission to the NIH/NCATS OligoTox Open Data Challenge Phase 2.
Summary
The dataset connects oligonucleotide sequence, chemical modification pattern, delivery platform, dose/exposure context, in vitro or translational liver-relevant assay context, controls, and toxicity readouts in a structured set of tables. The final dataset contains:
- 1,120 oligo records (1,000 generated non-control oligos + 120 controls)
- 5,600 assay instances across multiple time points and replicates
- 16,800 replicate-level toxicity readouts
- 127 tables comprising 8 core modeling tables (oligo metadata, aggregate chemistry, position-level modifications, biophysical, dose, assays, readouts, controls) plus per-source evidence modules and supporting metadata files
The dataset is intended for use in developing, training, benchmarking, and stress-testing in silico predictive models of oligonucleotide toxicity. It is not presented as experimentally measured wet-lab data; all values are computationally generated, with row-level provenance metadata distinguishing literature-grounded generated values from inferred and reported values.
Repository structure
/
βββ README.md β This file
βββ LICENSE β CC-BY-4.0 license text
β
βββ oligos.csv β
βββ chemical_modifications.csv β
βββ oligo_modification_positions.csv β 8 core modeling tables
βββ biophysical_properties.csv β Use these directly for predictive
βββ dose_exposure.csv β modeling tasks
βββ assays.csv β
βββ toxicity_readouts.csv β
βββ controls.csv β
β
βββ schema.json β
βββ data_dictionary.csv β
βββ data_dictionary_full.csv β
βββ dataset_manifest.json β Top-level documentation
βββ reproducibility_manifest.json β and validation
βββ validation_summary.csv β
βββ toxicity_readouts_calibration_audit.json β
β
βββ metadata/ (11 governance/provenance tables:
β assumptions, provenance, sources,
β triage log, gap map, etc.)
β
βββ evidence/ (105 per-source and broad-context
β evidence tables documenting
β literature-grounded generation
β logic for each source paper)
β
βββ figures/ (5 reference figures)
How to use
import pandas as pd
# Core modeling tables (root level)
oligos = pd.read_csv("oligos.csv")
mods = pd.read_csv("chemical_modifications.csv")
positions = pd.read_csv("oligo_modification_positions.csv")
biophys = pd.read_csv("biophysical_properties.csv")
dose = pd.read_csv("dose_exposure.csv")
assays = pd.read_csv("assays.csv")
readouts = pd.read_csv("toxicity_readouts.csv")
controls = pd.read_csv("controls.csv")
# Governance / provenance metadata (in metadata/ subfolder)
sources = pd.read_csv("metadata/sources.csv")
provenance = pd.read_csv("metadata/provenance.csv")
# Several tables share metadata columns (oligo_id, source_id, value_origin,
# etc.). When joining for modeling, select only the predictor columns you
# need from each secondary table to avoid duplicate-column collisions.
model_ready = (
readouts
.merge(assays[["assay_id", "model_system", "cell_model", "species",
"organoid_or_MPS", "assay_type", "replicate_count"]],
on="assay_id", how="left")
.merge(oligos[["oligo_id", "oligo_modality", "target_gene",
"sequence_5to3", "sequence_length",
"is_administered_oligo"]],
on="oligo_id", how="left")
.merge(mods[["oligo_id", "sugar_chemistry", "backbone_class",
"phosphorothioate_fraction", "GalNAc_conjugated"]],
on="oligo_id", how="left")
.merge(biophys[["oligo_id", "GC_content", "predicted_Tm_celsius",
"predicted_delta_G_kcal_mol",
"predicted_offtarget_hybridization_burden"]],
on="oligo_id", how="left")
.merge(dose[["oligo_id", "dose_nM", "exposure_duration_days"]],
on="oligo_id", how="left")
)
# Restrict to administered oligonucleotides for predictive modeling
model_ready = model_ready[model_ready["is_administered_oligo"] == True]
A baseline RandomForest classifier on standard predictors achieves overall accuracy of approximately 0.84 on the calibrated dataset, with per-class F1 scores of 0.95 (low-risk), 0.74 (moderate), and 0.49 (high-risk).
Dataset structure
Core modeling tables
| Table | Description |
|---|---|
oligos.csv |
Oligonucleotide identifiers, target genes, modality, 5'-to-3' sequence, sequence length, is_administered_oligo flag, control assignment, source role |
chemical_modifications.csv |
Aggregate chemistry per oligo: sugar chemistry, backbone class, phosphorothioate fraction, modification pattern, GalNAc conjugation, purity, characterization-method metadata |
oligo_modification_positions.csv |
Position-level chemical modifications: per-position base, sugar modification, backbone linkage, region (e.g., gapmer wing/gap, siRNA seed region), terminal conjugate, and provenance |
biophysical_properties.csv |
Predicted Tm, ΞG, GC content, off-target hybridization burden, sequence-derived risk fields |
dose_exposure.csv |
Dose/concentration, exposure duration, treatment frequency, exposure normalization |
assays.csv |
Model system, cell model, species/human-proxy flag, organoid/MPS status, replicate count, assay type |
toxicity_readouts.csv |
Replicate-level readouts: viability, ALT/AST proxy fold change, apoptosis, stress response, transcriptomic perturbation, immune activation, inflammatory context, overall risk score, hepatotoxicity label |
controls.csv |
Positive, negative, vehicle, and platform-specific control oligos with rationale, derived from public literature |
Supporting documentation tables
| File | Description |
|---|---|
schema.json |
Programmatic schema describing every table, column types, value ranges, and categorical values |
data_dictionary.csv |
Curated variable-level definitions for the core modeling tables |
data_dictionary_full.csv |
Auto-generated comprehensive column-level documentation across all dataset tables |
dataset_manifest.json |
Full inventory of dataset files with sizes |
reproducibility_manifest.json |
Reproducibility configuration: pipeline parameters, seeds, calibration step description |
validation_summary.csv |
Automated validation checks: row counts, identifier mapping, range checks, schema consistency |
assumptions.csv |
Explicit list of biological and modeling assumptions |
provenance.csv |
Provenance category definitions |
sources.csv |
Literature source metadata: paper titles, source IDs, relevance, license |
source_triage_log.csv |
Documentation of source-level inclusion, deferral, exclusion decisions |
information_gap_map.csv |
Identification of fields where future experimental data would have highest value |
model_readiness_report.csv |
Modeling-readiness summary across required predictor and outcome fields |
challenge_alignment_scorecard.csv |
Mapping of dataset components to challenge judging factors |
toxicity_readouts_calibration_audit.json |
Full specification of the stochastic readout calibration step (random seed, per-readout sigmas, score weights, label fractions) |
figures/ |
Five reference figures: label distribution before/after calibration, classifier performance, risk score distribution, predictor distributions, top source contributors |
Per-source evidence modules
The dataset includes per-paper or per-context evidence tables (e.g.,
hsd17b13_genetics_aso_translation.csv, pnpla3_azd2693_precision_mash.csv,
galnac_sirna_offtarget_rat_hepatotoxicity.csv) that record the
literature-grounded generation logic applied for each source. These
tables document which design rationale, control logic, or readout
constraint was contributed by each source.
Provenance
Every generated value carries a provenance label, which can take one of five values:
reported_in_paperβ value reported directly in a source paperextracted_from_paperβ value extracted from a source paper's tables/figuresinferred_from_paperβ value inferred from source-level reasoningliterature_grounded_generatedβ value generated within literature-informed boundsnot_reportedβ value not available
Toxicity readouts are stochastically calibrated with assay-specific
noise to produce realistic predictive structure for in silico modeling.
The full calibration specification is recorded in
toxicity_readouts_calibration_audit.json.
Limitations
- This dataset is computationally generated; no physical oligonucleotides were synthesized, purified, administered, or assayed.
- The dataset is intended for in silico model development, schema evaluation, and benchmarking. It is not intended as direct evidence for regulatory decision-making.
- The hepatotoxicity label distribution (60% low / 30% moderate / 10% high) is a deliberate benchmark stratification chosen to produce a non-trivial classification problem with both common and rare strata; it is not a claim about wet-lab oligonucleotide toxicity prevalence.
- Of the 1,120 rows in
oligos.csv, 1,089 represent oligos with explicit sequences and 31 represent context records without an administered oligo: vehicle/mock controls, clinical risk-score contexts, extracellular-vesicle delivery contexts, small-molecule rescue contexts, and non-administered injury-model contexts. Each row carries anis_administered_oligoboolean column for unambiguous filtering. Users restricting analysis to sequence-bearing oligos should filter onis_administered_oligo == True(equivalent tosequence_length > 0). Context records additionally carry anoligo_modalityvalue that explicitly identifies their non-oligo nature (e.g.,vehicle_mock,context_not_administered_oligo,extracellular_vesicle_context_not_oligo,clinical-risk-score-context). - Original source PDFs are not redistributed; sources are identified through title-level metadata only.
Citation
If you use this dataset, please cite:
DBbun LLC. OligoTox Phase 2 Dataset: A computationally generated,
literature-informed dataset for oligonucleotide-associated hepatotoxicity
modeling. Hugging Face Datasets, 2026.
Related work
DBbun LLC has previously released open synthetic biomedical datasets including the MELD-Plus 1M cohort, the UK Biobank ASCVD 10M cohort, and the Insomnia 1M cohort, all available under the DBbun namespace on Hugging Face.
- Downloads last month
- 49